1 completed, 1 not yet recruiting. 1 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Completed 1 |
| Phase 3 | 1 | Not yet recruiting 1 |
Follow Thrombocytopenia Purpura: new trials by email Literature Review of Thrombocytopenia Purpura trials Research Report on Thrombocytopenia Purpura
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| The Holistic Study Avatrombopag, Rituximab (Arm B) - Thrombocytopenia Purpura | Phase 3 | Not yet recruiting | Ostfold Hospital Trust | 220 | 2025-09-15 | 2025-09-09 |
| to Evaluate the Efficacy and Safety of Eltrombopag for Immune Thrombocytopenia With Chronic HBV Infection Eltrombopag - Thrombocytopenia Purpura, Chronic HBV Infection | Phase 2 | Completed | Institute of Hematology & Blood Diseases Hospital, China | 48 | 2018-12-04 | 2026-02-11 |
Purpura, Thrombocytopenic (2) · Purpura, Thrombocytopenic, Idiopathic (1) · Thrombocytopenia (1)
Blood Coagulation Disorders (2) · Blood Platelet Disorders (2) · Cytopenia (2) · Hematologic Diseases (2) · Hemic and Lymphatic Diseases (2) · Hemorrhage (2) · Immune System Diseases (2) · Pathologic Processes (2) · Pathological Conditions, Signs and Symptoms (2) · Purpura (2) · Signs and Symptoms (2) · Skin Manifestations (2) · Thrombotic Microangiopathies (2) · Autoimmune Diseases (1) · Hemorrhagic Disorders (1)
Rituximab (1) · avatrombopag (1) · eltrombopag (1)
Institute of Hematology & Blood Diseases Hospital, China (1) · Ostfold Hospital Trust (1)
China (1)